DeepMed Research

I.M. Sechenov First Moscow State Medical University

🇷🇺Russia

Country: 🇷🇺Russia

Ownership: Private

Established: 1758-01-01

Employees: 5K

Market Cap: -

Website: http://www.mma.ru

Clinical Trials

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Not Applicable

Conditions: Renal Cell Carcinoma

Interventions: Procedure: Off-clamp partial nephrectomy
Procedure: On-clamp partial nephrectomy

First Posted Date: 2021-03-16

Last Posted Date: 2021-03-16

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 60

Registration Number: NCT04798963

Locations: 🇷🇺
Sechenov University., Moscow, Russian Federation

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Not Applicable

Completed

Conditions: Vascular Stiffness
Toll-like Receptors
Liver Fibroses
Metabolic Syndrome
Trimethylamine N-oxyde

Interventions: Procedure: Simulating Interval hypoxic-hyperoxic training (IHHT) using respiratory therapy unit ReOxy.
Procedure: Interval hypoxic-hyperoxic training (IHHT) using respiratory therapy unit ReOxy.

First Posted Date: 2021-03-10

Last Posted Date: 2021-03-10

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 62

Registration Number: NCT04791397

Locations: 🇷🇺
University Clinical Hospital №1 Sechenov University, Moscow, Russian Federation

Pulse Wave Parameters in the Assessment of Systolic Function of the Left Ventricle.

Completed

Conditions: Heart Failure
Hypertension

Interventions: Device: pulse wave recording, echocardiography.

First Posted Date: 2021-03-09

Last Posted Date: 2022-12-07

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 400

Registration Number: NCT04788342

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

Sodium-glucose Cotransporter Type 2 Inhibitors for Acute Cardiorenal Syndrome Prevention

Phase 4

Completed

Conditions: Congestive Heart Failure

Interventions: Drug: Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin, inotropic agents, vasopressors), plus dapagliflozin (Forxiga; MP-002596)

First Posted Date: 2021-03-03

Last Posted Date: 2022-12-07

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 370

Registration Number: NCT04778787

Locations: 🇷🇺
Сity Сlinical Нospital number 7, Moscow, Russian Federation
🇷🇺
University Clinical Hospital number 1, Moscow, Russian Federation

Individual Preoperative Planning for RSA

Not Applicable

Conditions: Proximal Humeral Fracture
Shoulder Osteoarthritis
Avascular Necrosis of Humerus

Interventions: Procedure: reverse shoulder arthroplasty

First Posted Date: 2021-02-21

Last Posted Date: 2021-02-21

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 65

Registration Number: NCT04762667

Locations: 🇷🇺
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation

WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane

Not Applicable

Recruiting

Conditions: Postoperative Delirium
Agitation, Emergence
Postoperative Cognitive Dysfunction

Interventions: Procedure: WashIn /WashOut

First Posted Date: 2021-02-21

Last Posted Date: 2024-02-09

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 200

Registration Number: NCT04765488

Locations: 🇷🇺
Clinical hospital №1 of the I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
🇷🇺
Moscow Scientific Clinical Center, Moscow, Russian Federation
🇷🇺
Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy, Moscow, Russian Federation

Prognosis and Course of COVID-19 Infection in Hospitalised Patients

Completed

Conditions: SARS-CoV Infection
Covid19

First Posted Date: 2021-02-12

Last Posted Date: 2023-01-26

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 345

Registration Number: NCT04752085

Locations: 🇷🇺
University Hospital #4, Moscow, Russian Federation
🇷🇺
University Hospital #1, Moscow, Russian Federation

Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate

Not Applicable

Conditions: Bladder Cancer

Interventions: Procedure: en bloc resection, morcellation
Procedure: piecemeal resection, tissue removal by loop

First Posted Date: 2021-02-11

Last Posted Date: 2021-02-21

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 180

Registration Number: NCT04750590

Locations: 🇷🇺
Institute for Urology and Reproductive Health, Sechenov University., Moscow, Russian Federation

Efficacy and Safety of Tofacitinib in Patients With COVID-19 Pneumonia

Phase 2

Completed

Conditions: COVID-19

Interventions: Drug: Tofacitinib

First Posted Date: 2021-02-11

Last Posted Date: 2021-02-15

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 414

Registration Number: NCT04750317

Locations: 🇷🇺
Sechenov First Moscow State Medical University (Sechenov University) - University Clinical Hospital, Moscow, Russian Federation

Prospective Two-arm Study of Fertility in Men With COVID-19

Not Applicable

Conditions: Covid19
Fertility Issues

Interventions: Diagnostic Test: Sperm test
Diagnostic Test: hormone levels (testosterone, FSH, LH, prolactin)
Diagnostic Test: SARS-CoV-2 Ig G levels
Other: Testis pathology samples

First Posted Date: 2021-01-20

Last Posted Date: 2021-07-22

Lead Sponsor: I.M. Sechenov First Moscow State Medical University

Target Recruit Count: 88

Registration Number: NCT04716179

Locations: 🇷🇺
Sechenov University., Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy